Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Ann Surg Oncol. 2014 Aug 14;22(5):1634–1638. doi: 10.1245/s10434-014-3987-9

TABLE 3.

Disease recurrence after complete cytoreduction and hyperthermic intraperitoneal chemotherapy

No hepatic involvement (n = 433) Hepatic involvement (n = 37) p value
Recurrence, n/N (%)
 Colorectal 57/107 (53.3) 11/17 (64.7) 0.44
 Low-grade appendix 20/118 (16.9) 2/5 (40.0) 0.22
Median time to recurrence, months
 Colorectal 12.0 6.8 0.001
 Low-grade appendix 128.3 118.9 0.23
Site of recurrence, n/N (% of recurrences)
 Liver
  Colorectal 22/57 (38.6) 2/11 (18.2) 0.30
  Low-grade appendix 6/20 (30.0) 1/2 (50.0) 1.00
 Peritoneum
  Colorectal 21/57 (36.8) 5/11 (45.5) 0.74
  Low-grade appendix 13/20 (65.0) 1/2 (50.0) 1.00
Extra-abdominal
  Colorectal 14/57 (24.6) 4/11 (36.4) 0.46
  Low-grade appendix 1/20 (5.0) 1.00